MINIMAL RESIDUAL DISEASE
Clinical trials for MINIMAL RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new MINIMAL RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for MINIMAL RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on returning leukemia in new trial
Disease control Recruiting nowThis early-stage trial tests a new treatment for children and adults (ages 0-80) whose leukemia has come back or not responded after a donor stem cell transplant. The treatment involves taking donor immune cells, adding a special receptor so they can recognize and attack leukemia…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New combo aims to wipe out lingering cancer cells in colorectal patients
Disease control Recruiting nowThis study tests whether a combination of two drugs, fruquintinib and tislelizumab, can control colorectal cancer in people who still have signs of minimal residual disease (MRD) after completing standard chemotherapy. About 20 adults with stable colorectal cancer and positive ct…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Engineered immune cells take aim at lingering colorectal cancer
Disease control Recruiting nowThis early-phase trial tests a new combination treatment for people with colorectal cancer who have minimal residual disease (MRD) — tiny amounts of cancer left after standard therapy. The treatment uses specially engineered natural killer (NK) cells from donated cord blood, desi…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New stem cell transplant could lower risk of severe side effects in blood cancer patients
Disease control Recruiting nowThis study tests a new type of stem cell transplant for children and adults with blood cancers like leukemia. The transplant uses a special process to remove certain immune cells, which may lower the chance of the donor cells attacking the patient's body (graft-versus-host diseas…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
Massive cancer biorepository aims to fuel precision medicine
Knowledge-focused Recruiting nowThis study is creating a large collection of blood and tissue samples and health information from 100,000 adults with cancer. The goal is to store these samples and data so researchers can use them to develop better tests and treatments. Participants provide consent and samples a…
Matched conditions: MINIMAL RESIDUAL DISEASE
Sponsor: Caris Science, Inc. • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
AI blood test could spot lung cancer return earlier
Knowledge-focused Recruiting nowThis study looks at whether advanced blood tests and artificial intelligence can help detect lung cancer recurrence earlier and without invasive procedures. About 100 adults who had surgery for stage IB-IIIA lung cancer and received standard chemo-immunotherapy before surgery wil…
Matched conditions: MINIMAL RESIDUAL DISEASE
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:06 UTC